questionText: To ask the Secretary of State for Health and Social Care, if he will make an assessment of the the approval process of (a) high tariff drugs (b) the use of Obinutuzumab in patients with lupus who have experienced severe infusion reactions with rituximab.
answerText: The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations on whether new licensed medicines, including high cost medicines, should be routinely funded by the National Health Service in England, based o...
heading: Drugs: Licensing